SEC Form 4 · accession 0001144204-15-030267
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srini Conjeevaram
Director
Period of report
May 12, 2015
Accepted (ET)
May 13, 2015 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2015 | M | 8,750 | $3.36 | A | 57,000 | D | |
| Common StockF1 | May 12, 2015 | F | 4,158 | $7.07 | D | 52,842 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $3.36 | May 12, 2015 | M | 8,750 | D | May 12, 2005 | May 12, 2015 | Common Stock | 8,750 | 0 | D |
Explanation of responses
- F1Shares delivered in connection with the cashless exercise of 8,750 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $3.36, as reported herein.
- F2The options, granted pursuant to the issuer's stock option plan on May 12, 2005, vested on the first anniversary of the date of grant.
- F3The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash consideration.